ImmunoVec

Funding and NIH signals

• SEC Form D raise Raised $12.71M (Form D filed Jul 14, 2026). SEC Form D 0001231919-26-000761 (Jul 14, 2026)
  Evidence (1 event)

  • Jul 14, 2026 · SEC Form D 0001231919-26-000761
    Name of Issuer: ImmunoVec, Inc.; CIK: 1914272; Address: Los Angeles, CA; Submission type: D; Filing date: 2026-07-14; Industry Group: Other Technology; Date of First Sale: 2026-06-29; Types of Securities Offered: Equity, Security to be acquired, Other (Preferred Stock and Common Stock issuable upon conversion thereof. Total Offering Amount and Total Amount Sold include conversion of the previously issued convertible securities.); Business combination transaction: false; Total Offering Amount: 14999944; Total Amount Sold: 12705822; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals